Outcomes of Live Virus Vaccination in Patients With Vascular Anomalies Being Treated With Sirolimus
Svatava Merkle(Cincinnati Children's Hospital Medical Center), Elissa Engel(Cincinnati Children's Hospital Medical Center), Rebecca Marsh(Cincinnati Children's Hospital Medical Center), Kiersten Ricci(Cincinnati Children's Hospital Medical Center), Adrienne M. Hammill(Cincinnati Children's Hospital Medical Center), Kelly Blache(Cincinnati Children's Hospital Medical Center)
Cited by 0
Related Papers
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy
|Transplantation and Cellular Therapy|2021|180
Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham–Stout disease
|Pediatric Blood & Cancer|2019|126
Vascular Anomalies
|Hematology/Oncology Clinics of North America|2019|122
Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey
|Frontiers in Immunology|2020|81
How we approach the diagnosis and management of complex lymphatic anomalies
|Pediatric Blood & Cancer|2021|52